Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 664 of 6351
-
New combo therapy may help women with early breast cancer avoid mastectomy
Disease control By invitation onlyThis is a phase II single-center single-arm clinical study designed to analyze the efficacy and safety of trastuzumab combined with taxane neoadjuvant therapy for HER2-positive breast carcinoma in situ (or with invasive carcinoma).
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Which drug cuts C-Section bleeding best? tranexamic acid vs misoprostol put to the test
Disease control CompletedBrief Summary The goal of this clinical trial is to compare two medicines, intravenous tranexamic acid and rectal misoprostol, for reducing blood loss in women undergoing cesarean section. The study will also compare how much hemoglobin (a measure of blood loss) decreases after …
Phase 4 • Sponsor: Medicare Hospital (Pvt) Limited • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a shorter TB regimen transform child care?
Disease control Completed"Evaluation of the implementation of the shorter treatment regimen for children and adolescents with non-severe TB in Zambia" is a parallel and convergent mixed methods evaluation study of implementation and clinical outcomes of STR in real-world settings. The study enrolled care…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThe purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Can a freezing needle outperform standard biopsy for lung nodules?
Diagnosis By invitation onlyThis study aims to systematically compare the diagnostic efficacy, specimen quality, and complication rates of the cryobiopsy needle technique(CassiII rotational core biopsy) versus the automated biopsy technique in the biopsy of pulmonary nodules, thereby providing a reliable ev…
Sponsor: Beijing Chao Yang Hospital • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Do complex heart procedures expose patients to more harmful radiation and contrast?
Knowledge-focused OngoingIn France and Italy, approximately 240,000 percutaneous coronary angioplasties (PCI) are performed annually, with an increasing number of complex procedures, including those involving the left coronary common trunk, a bifurcation, chronic occlusion, or requiring Rotablator Rotary…
Sponsor: Centre Cardiologique du Nord • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can a diabetes drug protect kidneys in heart failure patients?
Disease control Recruiting nowEffects of Empagliflozin compared with placebo in cardiorenal syndrome type 1, evaluated by MAKE30.
Phase 2/3 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy plus chemo shows promise against stomach cancer in early trial
Disease control Recruiting nowThis study is a single-arm, prospective, phase II clinical trial. The patients are diagnosed with resectable locally advanced (cT3-4N+M0) gastric adenocarcinoma and esophageal gastric adenocarcinoma that had not been treated before. After signing the informed consent form, patie…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for HAE patients: experimental drug aims to slash attack rate
Disease control OngoingA Phase 2 in Adult Subjects with Hereditary Angioedema
Phase 2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New study aims to boost HIV prevention in black women facing violence
Prevention Recruiting nowU.S. epidemiological data indicates that Black women are a high-risk HIV disparity group, yet initiation of novel prevention strategies like pre-exposure prophylaxis (PrEP) among this group is stagnant. Socio-structural challenges like intimate partner violence and gendered racis…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Can a personalized video and phone call get more teens the HPV vaccine?
Vaccine Recruiting nowDevelop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled…
Sponsor: University of California, Davis • Aim: Vaccine
Last updated Aug 13, 2026 00:00 UTC
-
Can a traditional tablet turn back precancerous stomach changes?
Disease control Recruiting nowThe goal of this clinical trial is to investigate the efficacy and safety of Weifuchun tablet in treating gastric intestinal metaplasia in Helicobacter pylori-negative adults. The main questions it aims to answer are: Does Weifuchun tablet promote the regression of gastric intest…
Phase 4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Five-Day NSAID course curb opioid dependence after severe bone injuries?
Disease control Recruiting nowThe goal of this randomized clinical trial is to learn if the use of a low-dose nonsteroidal anti-inflammatory drug (NSAID), ketorolac, reduces the rate of chronic opioid use in orthopaedic trauma patients. The main questions this study aims to answer are: 1. Are patients who ar…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Wearables could decode chronic pain in teens
Knowledge-focused OngoingThe purpose of this study is to evaluate the feasibility and acceptability of using wearable digital health technology for continuous monitoring of physiological, sleep, and physical activity data in adolescents with chronic musculoskeletal (MSK) pain. This research aims to devel…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Could a Twice-Yearly shot help kids with rare high cholesterol?
Disease control Recruiting nowThis is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New smart bomb for liver cancer: radiation drug targets tumors only
Disease control Recruiting nowIn this study, researchers want to learn about the safety of a new drug, BAY 3547926, and how well the drug works in people with a type of liver cancer called advanced hepatocellular carcinoma (HCC), which has a special protein called Glypican 3 (GPC3). Researchers want to find t…
Phase 1 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New vaccine aims to protect kids from pneumonia – study underway
Vaccine OngoingThe purpose of this study is to evaluate the safety and immunogenicity of PCV21 versus 20vPCV ( 20-valent pneumococcal conjugate vaccine, Prevnar 20) for catch-up vaccination in infants (7 to 11 MoA-Months of age), toddlers (12 to 23 MoA), and children/adolescents (2 to 5 YoA and…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
New drug aims to save Insulin-Making cells in type 1 diabetes
Disease control OngoingThis is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of brivekimig in comparison to placebo to preserve β-cell function in participants with recently diagnosed …
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New schizophrenia pill shows promise in major trial
Disease control Recruiting nowEvaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Electromagnetic fields join the fight against pancreatic cancer
Disease control Recruiting nowThe goal of this study is to learn if the combination of nab-paclitaxel, gemcitabine and an Amplitude-Modulated Radiofrequency Electromagnetic Fields device (Therabionic P1) is safe and effective for patients with adenocarcinoma of the pancreas.
Phase 2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC